Glucose Absorption Into the Small Intestine

Glucose enters intestinal epithelial cells via the sodium-glucose symporter SGLT1 located on the apical membrane. Two sodium ions bind to SGLT1 first, enabling one glucose molecule to bind against its concentration gradient. After transport into the cell, the sodium and glucose are released, and the transporter returns to its original conformation, ready for the next cycle.

The sodium-potassium pump on the basolateral membrane actively pumps three sodium ions out of the cell in exchange for two potassium ions. This maintains a low cytosolic sodium concentration, preserving the sodium gradient needed to drive glucose uptake via SGLT1. The pump's activity is essential for sustaining the electrochemical gradient that powers glucose absorption.

Glucose exits the intestinal epithelial cell through facilitated transport via the GLUT2 uniporter on the basolateral membrane. GLUT2 transports accumulated intracellular glucose down its concentration gradient into the bloodstream without requiring energy. This passive transport step completes the transcellular pathway for glucose absorption.

Potassium channels on the basolateral domain continuously pump excess potassium ions out of the cell, regulating intracellular potassium concentration. This channel activity helps maintain the membrane potential required for SGLT1 function and supports the driving force for sodium-dependent glucose uptake into the intestinal epithelial cells.

Glucose absorption occurs in two stages: import into intestinal epithelial cells from the apical side via SGLT1, and export through the basolateral side via GLUT2. The first stage is active and couples sodium ion binding to glucose transport against its concentration gradient. The second stage is passive, moving glucose down its concentration gradient into the blood.

Glucose absorption is electrogenic and depends on the membrane potential of intestinal epithelial cells, which regulates SGLT1 activity. The sodium-potassium pump and potassium channels maintain this membrane potential by controlling ion gradients. A stable membrane potential is essential for driving the sodium-dependent uptake of glucose into the cell.

Metabolic disorders like diabetes show increased SGLT1 expression, contributing to elevated glucose absorption in the small intestine. Reducing SGLT1-mediated transport of glucose appears to be a therapeutic target for diabetes treatment. Lowering SGLT1 activity could help decrease excessive glucose uptake and improve blood glucose control in diabetic patients.